Filing Details
- Accession Number:
- 0001209191-11-053340
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-10-31 16:19:20
- Reporting Period:
- 2011-10-28
- Filing Date:
- 2011-10-31
- Accepted Time:
- 2011-10-31 16:19:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1333170 | Nxstage Medical Inc. | NXTM | Electromedical & Electrotherapeutic Apparatus (3845) | 043454702 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1519023 | Michael Miller | C/O Nxstage Medical, Inc. 439 South Union Street Lawrence MA 01843 | President, International | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-10-28 | 1,250 | $0.00 | 2,087 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-10-28 | 413 | $23.70 | 1,674 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2011-10-28 | 1,250 | $0.00 | 1,250 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,500 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 9, 2011.
- Each restricted stock unit represents a contingent right to receive one share of the Company's common stock
- Executive was granted a time-based restricted stock unit award of 10,000 shares of common stock of the Company on April 25, 2011, and vesting in equal installments on a quarterly basis over a period of twenty-four months.
Billionaire Hedge Funds
